IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis

被引:141
作者
Singer, M [1 ]
Sansonetti, PJ [1 ]
机构
[1] Inst Pasteur, INSERM, Unite Pathogenie Microbienne Mol, U389, F-75015 Paris, France
关键词
D O I
10.4049/jimmunol.173.6.4197
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The lack of a mouse model of acute rectocolitis mimicking human bacillary dysentery in the presence of invasive Shigella is a major handicap to study the pathogenesis of the disease and to develop a Shigella vaccine. The inability of the mouse intestinal mucosa to elicit an inflammatory infiltrate composed primarily of polymorphonuclear leukocytes (PMN) may be due to a defect in epithelial invasion, in the sensing of invading bacteria, or in the effector mechanisms that recruit the PMN infiltrate. We demonstrate that the BALB/cJ mouse colonic epithelium not only can be invaded by Shigella, but also elicits an inflammatory infiltrate that, however, lacks PMN. This observation points to a major defect of mice in effector mechanisms, particularly the lack of expression of the CXC chemokine, IL-8. Indeed, this work demonstrates that the delivery of recombinant human IL-8, together with Shigella infection of the colonic epithelial surface, causes an acute colitis characterized by a strong PMN infiltrate that, by all criteria, including transcription profiles of key mediators of the innate/inflammatory response and histopathological lesions, mimics bacillary dysentery. This is a major step forward in the development of a murine model of bacillary dysentery.
引用
收藏
页码:4197 / 4206
页数:10
相关论文
共 70 条
  • [1] MXID, AN OUTER-MEMBRANE PROTEIN NECESSARY FOR THE SECRETION OF THE SHIGELLA-FLEXNERI IPA INVASINS
    ALLAOUI, A
    SANSONETTI, PJ
    PARSOT, C
    [J]. MOLECULAR MICROBIOLOGY, 1993, 7 (01) : 59 - 68
  • [2] Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis
    Ameho, CK
    Adjei, AA
    Harrison, EK
    Takeshita, K
    Morioka, T
    Arakaki, Y
    Ito, E
    Suzuki, I
    Kulkarni, AD
    Kawajiri, A
    Yamamoto, S
    [J]. GUT, 1997, 41 (04) : 487 - 493
  • [3] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P197
  • [4] Parameters underlying successful protection with live attenuated mutants in experimental shigellosis
    Bernardini, ML
    Arondel, J
    Martini, I
    Aidara, A
    Sansonetti, PJ
    [J]. INFECTION AND IMMUNITY, 2001, 69 (02) : 1072 - 1083
  • [5] Colitis in transgenic and knockout animals as models of human inflammatory bowel disease
    Bhan, AK
    Mizoguchi, E
    Smith, RN
    Mizoguchi, A
    [J]. IMMUNOLOGICAL REVIEWS, 1999, 169 : 195 - 207
  • [6] Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4
    Boirivant, M
    Fuss, IJ
    Chu, A
    Strober, W
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) : 1929 - 1939
  • [7] BOZIC CR, 1995, J IMMUNOL, V154, P6048
  • [8] BOZIC CR, 1994, J BIOL CHEM, V269, P29355
  • [9] Analysis of virulence and inflammatory potential of Shigella flexneri purine biosynthesis mutants
    Cersini, A
    Martino, MC
    Martini, I
    Rossi, G
    Bernardini, ML
    [J]. INFECTION AND IMMUNITY, 2003, 71 (12) : 7002 - 7013
  • [10] Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945